Compounds > esorubicin
Page last updated: 2024-09-04

esorubicin and epicinchonine

esorubicin has been researched along with epicinchonine in 1 studies

Compound Research Comparison

Studies
(esorubicin)		Trials
(esorubicin)		Recent Studies (post-2010)
(esorubicin)		Studies
(epicinchonine)		Trials
(epicinchonine)		Recent Studies (post-2010) (epicinchonine)
11520087824

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chauffert, B; Dimanche-Boitrel, MT; Duchamp, O; Genne, P; Gutierrez, G; Martin, F; Mauvernay, RY; Petit, JM1

Other Studies

1 other study(ies) available for esorubicin and epicinchonine

ArticleYear
Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo.
    Cancer research, 1992, May-15, Volume: 52, Issue:10

    Topics: Animals; Antibiotics, Antineoplastic; Cinchona Alkaloids; Colonic Neoplasms; Doxorubicin; Drug Resistance, Microbial; Drug Synergism; Female; Male; Mice; Mice, Inbred BALB C; Quinine; Rats; Rats, Inbred Strains; Tumor Cells, Cultured

1992